163 related articles for article (PubMed ID: 36626550)
1. ATOH8 binds SMAD3 to induce cellular senescence and prevent Ras-driven malignant transformation.
Liu X; Li X; Wang S; Liu Q; Feng X; Wang W; Huang Z; Huang Y; Wu J; Cai M; Cai X; Xu X; Cai J; Li M
Proc Natl Acad Sci U S A; 2023 Jan; 120(3):e2208927120. PubMed ID: 36626550
[TBL] [Abstract][Full Text] [Related]
2. TGF-beta signaling engages an ATM-CHK2-p53-independent RAS-induced senescence and prevents malignant transformation in human mammary epithelial cells.
Cipriano R; Kan CE; Graham J; Danielpour D; Stampfer M; Jackson MW
Proc Natl Acad Sci U S A; 2011 May; 108(21):8668-73. PubMed ID: 21555587
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic ras represses transforming growth factor-beta /Smad signaling by degrading tumor suppressor Smad4.
Saha D; Datta PK; Beauchamp RD
J Biol Chem; 2001 Aug; 276(31):29531-7. PubMed ID: 11371552
[TBL] [Abstract][Full Text] [Related]
4. Smad3 protein levels are modulated by Ras activity and during the cell cycle to dictate transforming growth factor-beta responses.
Daly AC; Vizán P; Hill CS
J Biol Chem; 2010 Feb; 285(9):6489-97. PubMed ID: 20037158
[TBL] [Abstract][Full Text] [Related]
5. Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta.
Feng XH; Lin X; Derynck R
EMBO J; 2000 Oct; 19(19):5178-93. PubMed ID: 11013220
[TBL] [Abstract][Full Text] [Related]
6. Mitogenic conversion of transforming growth factor-beta1 effect by oncogenic Ha-Ras-induced activation of the mitogen-activated protein kinase signaling pathway in human prostate cancer.
Park BJ; Park JI; Byun DS; Park JH; Chi SG
Cancer Res; 2000 Jun; 60(11):3031-8. PubMed ID: 10850453
[TBL] [Abstract][Full Text] [Related]
7. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW
Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833
[TBL] [Abstract][Full Text] [Related]
8. Smad3 regulates senescence and malignant conversion in a mouse multistage skin carcinogenesis model.
Vijayachandra K; Lee J; Glick AB
Cancer Res; 2003 Jul; 63(13):3447-52. PubMed ID: 12839923
[TBL] [Abstract][Full Text] [Related]
9. CBL enhances breast tumor formation by inhibiting tumor suppressive activity of TGF-β signaling.
Kang JM; Park S; Kim SJ; Hong HY; Jeong J; Kim HS; Kim SJ
Oncogene; 2012 Dec; 31(50):5123-31. PubMed ID: 22310290
[TBL] [Abstract][Full Text] [Related]
10. STAT3-mediated SMAD3 activation underlies Oncostatin M-induced Senescence.
Bryson BL; Junk DJ; Cipriano R; Jackson MW
Cell Cycle; 2017 Feb; 16(4):319-334. PubMed ID: 27892764
[TBL] [Abstract][Full Text] [Related]
11. Ras inhibits TGF-β-induced KLF5 acetylation and transcriptional complex assembly via regulating SMAD2/3 phosphorylation in epithelial cells.
Guo P; Xing C; Fu X; He D; Dong JT
J Cell Biochem; 2020 Mar; 121(3):2197-2208. PubMed ID: 31724223
[TBL] [Abstract][Full Text] [Related]
12. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation.
Chen H; Yang T; Wang MC; Chen DQ; Yang Y; Zhao YY
Phytomedicine; 2018 Mar; 42():207-218. PubMed ID: 29655688
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor and mutant p53 expand an esophageal cellular subpopulation capable of epithelial-to-mesenchymal transition through ZEB transcription factors.
Ohashi S; Natsuizaka M; Wong GS; Michaylira CZ; Grugan KD; Stairs DB; Kalabis J; Vega ME; Kalman RA; Nakagawa M; Klein-Szanto AJ; Herlyn M; Diehl JA; Rustgi AK; Nakagawa H
Cancer Res; 2010 May; 70(10):4174-84. PubMed ID: 20424117
[TBL] [Abstract][Full Text] [Related]
14. Loss of phosphatase and tensin homologue increases transforming growth factor beta-mediated invasion with enhanced SMAD3 transcriptional activity.
Hjelmeland AB; Hjelmeland MD; Shi Q; Hart JL; Bigner DD; Wang XF; Kontos CD; Rich JN
Cancer Res; 2005 Dec; 65(24):11276-81. PubMed ID: 16357132
[TBL] [Abstract][Full Text] [Related]
15. The transcriptional regulatory function of p53 is essential for suppression of mouse skin carcinogenesis and can be dissociated from effects on TGF-beta-mediated growth regulation.
Ponnamperuma RM; King KE; Elsir T; Glick AB; Wahl GM; Nister M; Weinberg WC
J Pathol; 2009 Oct; 219(2):263-74. PubMed ID: 19718706
[TBL] [Abstract][Full Text] [Related]
16. MYOCD and SMAD3/SMAD4 form a positive feedback loop and drive TGF-β-induced epithelial-mesenchymal transition in non-small cell lung cancer.
Tong X; Wang S; Lei Z; Li C; Zhang C; Su Z; Liu X; Zhao J; Zhang HT
Oncogene; 2020 Apr; 39(14):2890-2904. PubMed ID: 32029901
[TBL] [Abstract][Full Text] [Related]
17. Differential oncogenic Ras signaling and senescence in tumor cells.
Bihani T; Mason DX; Jackson TJ; Chen SC; Boettner B; Lin AW
Cell Cycle; 2004 Sep; 3(9):1201-7. PubMed ID: 15492501
[TBL] [Abstract][Full Text] [Related]
18. Smad3 deficiency inhibits v-ras-induced transformation by suppression of JNK MAPK signaling and increased farnesyl transferase inhibition.
Arany PR; Rane SG; Roberts AB
Oncogene; 2008 Apr; 27(17):2507-12. PubMed ID: 17952112
[TBL] [Abstract][Full Text] [Related]
19. Zyxin is a transforming growth factor-β (TGF-β)/Smad3 target gene that regulates lung cancer cell motility via integrin α5β1.
Mise N; Savai R; Yu H; Schwarz J; Kaminski N; Eickelberg O
J Biol Chem; 2012 Sep; 287(37):31393-405. PubMed ID: 22778267
[TBL] [Abstract][Full Text] [Related]
20. Functional characterization of transforming growth factor beta signaling in Smad2- and Smad3-deficient fibroblasts.
Piek E; Ju WJ; Heyer J; Escalante-Alcalde D; Stewart CL; Weinstein M; Deng C; Kucherlapati R; Bottinger EP; Roberts AB
J Biol Chem; 2001 Jun; 276(23):19945-53. PubMed ID: 11262418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
